Request Deal Involvement

Foresite Capital-backed FS Development to merge with Gemini Therapeutics in a $216m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Argot Partners

pr advisors

Argot Partners

Stifel

financial advisors

Stifel

Goodwin Procter

legal advisors

Goodwin Procter

Goldman Sachs

financial advisors

Goldman Sachs

Leerink Partners

financial advisors

Leerink Partners

White & Case

legal advisors

White & Case

Jefferies & Company

financial advisors

Jefferies & Company

Sodali & Co

commercial advisors

Sodali & Co

or

Principals

GEMINI THERAPEUTICS

target

GEMINI THERAPEUTICS

FS DEVELOPMENT CORP

bidder

FS DEVELOPMENT CORP

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

ATLAS VENTURE LP

vendor

ATLAS VENTURE LP

ORBIMED ADVISORS LLC

vendor

ORBIMED ADVISORS LLC

LIGHTSTONE VENTURES

vendor

LIGHTSTONE VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Foresite Capital-backed FS Development to merge with Gemini Therapeutics in a $216m deal.